CNMD Stock Analysis: Buy, Sell, or Hold?
CNMD - CONMED Corporation
$38.39
1.08 (2.89%)
▲
HOLD
MODERATE Confidence
Last Updated: January 30, 2026
Earnings: Jan 28, 2026
0d
Get Alerted When CNMD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: CNMD shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: CNMD shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$70.47
Based on 8.9% avg growth
INTRINSIC VALUE TODAY
$43.76
12.3% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 9.2x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: CNMD is currently trading at $38.39, which is considered oversold relative to its 30-day fair value range of $39.73 to $42.82. From a valuation perspective, the stock is trading at a discount (Forward PE: 7.4) compared to its historical average (9.2). Remarkably, the market is currently pricing in an annual earnings decline of 7.0% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, CNMD is in a strong downtrend. Immediate support is located at $35.37, while resistance sits at $42.67.
Market Sentiment: CNMD has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $48.40 (+29.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, CNMD is in a strong downtrend. Immediate support is located at $35.37, while resistance sits at $42.67.
Market Sentiment: CNMD has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $48.40 (+29.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$39.73 -
$42.82
Company Quality Score
49/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.1%
Protect Your Profits
Holding CNMD? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 29.7% below Wall St target ($48.40)
- CAUTION: 5-day price weakness (-7.8%) - monitor closely
Fair Price Analysis
30-Day Fair Range
$39.73 -
$42.82
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$35.37
Resistance Level
$42.67
Current Trend
Strong Downtrend
Fundamental Context
Forward P/E (Next Year Est.)
7.42
Wall Street Target
$48.40
(+29.7%)
Revenue Growth (YoY)
6.7%
Earnings Growth (YoY)
-94.3%
Profit Margin
4.8%
Valuation Discount vs History
-7.0% cheaper
PE vs Historical
7.4 vs 9.2
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-7.0%
(market-implied from PE analysis)
1-Year Target
$34.70
(-7%)
2-Year Target
$32.27
(-14%)
3-Year Target
$30.01
(-20%)
3-Yr Target (if PE normalizes)
(PE: 7→9)
$37.19
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.3, Growth: 13.7%)
$164.71
(+342%)
Base:
(SPY PE: 7.4, Growth: 13.7%)
$54.84
(+47%)
Bear:
(PE: 6.3, Growth: 13.7%)
$46.61
(+25%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (19x PE), but valuation improves significantly next year (7x PE) as earnings recover.
Trailing PE: 18.87 | Current EPS (TTM): $2.05
Bull Case
$85.12
(+122%)
Analyst growth 100.0%, PE expands to 20.8
Base Case
$77.38
(+102%)
Market implied 100.0%, PE stable at 18.9
Bear Case
$26.31
(-32%)
Severe decline -20.0%, PE contracts to 16.0
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 7.4 to 9.2
Stabilization Target:
$46.23
(+23.9%)
PE Expansion Potential:
+23.9%
Last updated: January 31, 2026 5:52 AM ET
Data refreshes hourly during market hours. Next update: 6:52 AM
Data refreshes hourly during market hours. Next update: 6:52 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CNMD showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Charles Farkas
SELL
2000 shares
2025-09-12
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$124 | 59 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$427 | 68 BUY |
|
DXCM
DexCom Inc |
STRONG BUY
26 analysts |
$85 | 65 BUY |
|
ABT
Abbott Laboratories |
BUY
28 analysts |
$136 | 63 BUY |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$110 | 63 BUY |
Advanced CNMD Option Strategies
Professional options setups generated by AI based on today's CNMD price and gamma walls.
